03:38 AM EDT, 03/30/2026 (MT Newswires) -- Harold E Selick, Director, on March 26, 2026, sold 24,000 shares in Protagonist Therapeutics ( PTGX ) for $2,520,000. Following the Form 4 filing with the SEC, Selick has control over a total of 60,845 common shares of the company, with 60,845 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1377121/000110465926036318/xslF345X05/tm2610129-2_4seq1.xml